Johnson & Johnson Innovation - JJDC, Inc.
CIK 924020 · last filed 2026-01-08
Johnson & Johnson Innovation - JJDC, Inc. is a corporate insider who has filed 20 SEC Form 4 insider transactions across 7 companies since 2014. The most recent filing shows the insider sold $448.1K of CVRX on Jan 8, 2026. Across all open-market trades the lifetime net is −$90.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $19.8M across reported positions. The firm reports its address in New Brunswick, NJ. 58 SEC filings were submitted jointly with & Johnson Johnson.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NVRO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NEW BRUNSWICK, NJ 08901
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CVRX | 10%+ Owner | 4,024,861 | $1.42 | $5.72M | -$660.4K | 6 | 2026-01-08 |
| MGTX | 10%+ Owner | 0 | $9.21 | $0 | $0 | 1 | 2023-09-18 |
| INSP | 10%+ Owner | 197,863 | $71.11 | $14.07M | $0 | 1 | 2018-05-07 |
| NERV | 10%+ Owner | 0 | $2.30 | $0 | $0 | 1 | 2017-09-14 |
| NEVRO CORP (NVRO) Delisted | 10%+ Owner | 2,066,740 | $5.84 | $12.07M | -$95.42M | 2 | 2015-06-08 |
| Neurogene Inc. (AQXP) Delisted | 10%+ Owner | 1,664,821 | — | — | $5.38M | 7 | 2015-02-03 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 173,581 | $0.00 | $104 | $0 | 1 | 2014-02-11 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-08 | CVRX | Sell (S) | −44,674 | -$448.1K | EDGAR |
| 2025-11-14 | CVRX | Sell (S) | −2,000 | -$20.0K | EDGAR |
| 2024-03-06 | CVRX | Mixed | +1,215,710 | $5.3K | EDGAR |
| 2024-02-02 | CVRX | Other (J) | — | $0 | EDGAR |
| 2023-09-18 | MGTX | Other (J) | −6,641,064 | $0 | EDGAR |
| 2023-09-18 | CVRX | Other (J) | −3,495,575 | $0 | EDGAR |
| 2021-07-02 | CVRX | Conv (C) | +6,991,150 | $0 | EDGAR |
| 2018-07-20 | — | Conv (C) | +4,800,000 | $0 | |
| 2018-05-07 | INSP | Conv (C) | +470,502 | $0 | EDGAR |
| 2017-09-14 | NERV | Other (J) | −7,784,512 | -$778 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.